172 related articles for article (PubMed ID: 21190543)
21. What dictates the accumulation of desmosterol in the developing brain?
Jansen M; Wang W; Greco D; Bellenchi GC; di Porzio U; Brown AJ; Ikonen E
FASEB J; 2013 Mar; 27(3):865-70. PubMed ID: 23230282
[TBL] [Abstract][Full Text] [Related]
22. Desmosterol suppresses macrophage inflammasome activation and protects against vascular inflammation and atherosclerosis.
Zhang X; McDonald JG; Aryal B; Canfrán-Duque A; Goldberg EL; Araldi E; Ding W; Fan Y; Thompson BM; Singh AK; Li Q; Tellides G; Ordovás-Montanes J; García Milian R; Dixit VD; Ikonen E; Suárez Y; Fernández-Hernando C
Proc Natl Acad Sci U S A; 2021 Nov; 118(47):. PubMed ID: 34782454
[TBL] [Abstract][Full Text] [Related]
23. The Niemann-Pick C1 like 1 (NPC1L1) inhibitor ezetimibe improves metabolic disease via decreased liver X receptor (LXR) activity in liver of obese male mice.
Sugizaki T; Watanabe M; Horai Y; Kaneko-Iwasaki N; Arita E; Miyazaki T; Morimoto K; Honda A; Irie J; Itoh H
Endocrinology; 2014 Aug; 155(8):2810-9. PubMed ID: 24773344
[TBL] [Abstract][Full Text] [Related]
24. E2012-induced cataract and its predictive biomarkers.
Nakano-Ito K; Fujikawa Y; Hihara T; Shinjo H; Kotani S; Suganuma A; Aoki T; Tsukidate K
Toxicol Sci; 2014 Jan; 137(1):249-58. PubMed ID: 24085193
[TBL] [Abstract][Full Text] [Related]
25. Desmosterol and DHCR24: unexpected new directions for a terminal step in cholesterol synthesis.
Zerenturk EJ; Sharpe LJ; Ikonen E; Brown AJ
Prog Lipid Res; 2013 Oct; 52(4):666-80. PubMed ID: 24095826
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and activity evaluation of a series of cholanamides as modulators of the liver X receptors.
Martínez MD; Ghini AA; Dansey MV; Veleiro AS; Pecci A; Alvarez LD; Burton G
Bioorg Med Chem; 2018 Mar; 26(5):1092-1101. PubMed ID: 29428525
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of Δ24-dehydrocholesterol reductase activates pro-resolving lipid mediator biosynthesis and inflammation resolution.
Körner A; Zhou E; Müller C; Mohammed Y; Herceg S; Bracher F; Rensen PCN; Wang Y; Mirakaj V; Giera M
Proc Natl Acad Sci U S A; 2019 Oct; 116(41):20623-20634. PubMed ID: 31548397
[TBL] [Abstract][Full Text] [Related]
28. The endogenous regulator 24(S),25-epoxycholesterol inhibits cholesterol synthesis at DHCR24 (Seladin-1).
Zerenturk EJ; Kristiana I; Gill S; Brown AJ
Biochim Biophys Acta; 2012 Sep; 1821(9):1269-77. PubMed ID: 22178193
[TBL] [Abstract][Full Text] [Related]
29. Liver X receptors (LXRs). Part I: structure, function, regulation of activity, and role in lipid metabolism.
Wójcicka G; Jamroz-Wiśniewska A; Horoszewicz K; Bełtowski J
Postepy Hig Med Dosw (Online); 2007 Dec; 61():736-59. PubMed ID: 18063918
[TBL] [Abstract][Full Text] [Related]
30. The liver X receptor: control of cellular lipid homeostasis and beyond Implications for drug design.
Oosterveer MH; Grefhorst A; Groen AK; Kuipers F
Prog Lipid Res; 2010 Oct; 49(4):343-52. PubMed ID: 20363253
[TBL] [Abstract][Full Text] [Related]
31. Amiodarone disrupts cholesterol biosynthesis pathway and causes accumulation of circulating desmosterol by inhibiting 24-dehydrocholesterol reductase.
Simonen P; Li S; Chua NK; Lampi AM; Piironen V; Lommi J; Sinisalo J; Brown AJ; Ikonen E; Gylling H
J Intern Med; 2020 Nov; 288(5):560-569. PubMed ID: 32415867
[TBL] [Abstract][Full Text] [Related]
32. Liver X receptor modulators: effects on lipid metabolism and potential use in the treatment of atherosclerosis.
Fiévet C; Staels B
Biochem Pharmacol; 2009 Apr; 77(8):1316-27. PubMed ID: 19101522
[TBL] [Abstract][Full Text] [Related]
33. Liver X receptors as potential therapeutic targets in atherosclerosis.
Zhu Y; Li Y
Clin Invest Med; 2009 Oct; 32(5):E383-94. PubMed ID: 19796580
[TBL] [Abstract][Full Text] [Related]
34. The phospholipid transfer protein gene is a liver X receptor target expressed by macrophages in atherosclerotic lesions.
Laffitte BA; Joseph SB; Chen M; Castrillo A; Repa J; Wilpitz D; Mangelsdorf D; Tontonoz P
Mol Cell Biol; 2003 Mar; 23(6):2182-91. PubMed ID: 12612088
[TBL] [Abstract][Full Text] [Related]
35. Pharmacological characterization of a novel liver X receptor agonist with partial LXRα activity and a favorable window in nonhuman primates.
Kirchgessner TG; Martin R; Sleph P; Grimm D; Liu X; Lupisella J; Smalley J; Narayanan R; Xie Y; Ostrowski J; Cantor GH; Mohan R; Kick E
J Pharmacol Exp Ther; 2015 Feb; 352(2):305-14. PubMed ID: 25467132
[TBL] [Abstract][Full Text] [Related]
36. Liver X receptor activation promotes macrophage-to-feces reverse cholesterol transport in a dyslipidemic hamster model.
Briand F; Tréguier M; André A; Grillot D; Issandou M; Ouguerram K; Sulpice T
J Lipid Res; 2010 Apr; 51(4):763-70. PubMed ID: 19965597
[TBL] [Abstract][Full Text] [Related]
37. Regulation of the aldo-keto reductase gene akr1b7 by the nuclear oxysterol receptor LXRalpha (liver X receptor-alpha) in the mouse intestine: putative role of LXRs in lipid detoxification processes.
Volle DH; Repa JJ; Mazur A; Cummins CL; Val P; Henry-Berger J; Caira F; Veyssiere G; Mangelsdorf DJ; Lobaccaro JM
Mol Endocrinol; 2004 Apr; 18(4):888-98. PubMed ID: 14739254
[TBL] [Abstract][Full Text] [Related]
38. Antihyperlipidemic Activity of Gut-Restricted LXR Inverse Agonists.
Griffett K; Hayes M; Bedia-Diaz G; Appourchaux K; Sanders R; Boeckman MP; Koelblen T; Zhang J; Schulman IG; Elgendy B; Burris TP
ACS Chem Biol; 2022 May; 17(5):1143-1154. PubMed ID: 35417135
[TBL] [Abstract][Full Text] [Related]
39. Raising HDL cholesterol without inducing hepatic steatosis and hypertriglyceridemia by a selective LXR modulator.
Miao B; Zondlo S; Gibbs S; Cromley D; Hosagrahara VP; Kirchgessner TG; Billheimer J; Mukherjee R
J Lipid Res; 2004 Aug; 45(8):1410-7. PubMed ID: 15145986
[TBL] [Abstract][Full Text] [Related]
40. Regulation of the last two enzymatic reactions in cholesterol biosynthesis in rats: effects of BM 15.766, cholesterol, cholic acid, lovastatin, and their combinations.
Honda A; Shefer S; Salen G; Xu G; Batta AK; Tint GS; Honda M; Chen TC; Holick MF
Hepatology; 1996 Aug; 24(2):435-9. PubMed ID: 8690416
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
